Kim Hyunji, Lee Koeun, Ha Sejin, Shin Eonwoo, Ahn Kang-Min, Lee Jee-Ho, Ryu Jin-Sook
Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505 Republic of Korea.
Department of Oral and Maxillofacial Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505 Republic of Korea.
Nucl Med Mol Imaging. 2020 Dec;54(6):292-298. doi: 10.1007/s13139-020-00670-7. Epub 2020 Oct 19.
We aimed to evaluate the performance of hybrid bone single-photon emission computed tomography (SPECT)/computed tomography (CT) in predicting bone graft viability after maxillary or mandibular reconstructive surgery with vascularized bone grafts.
We retrospectively reviewed 46 bone planar scintigraphy and SPECT/CT images of 45 adult patients taken at 1 week (5-8 days) after maxillary or mandibular reconstructive surgery with vascularized bone grafts. By visual analysis, two nuclear medicine physicians scored the uptake degrees of each bone graft segment compared with the calvarium uptake on planar bone scintigraphy and SPECT/CT, respectively (0 = absence of uptake, 1 = less uptake, 2 = similar uptake, and 3 = more uptake). The imaging results were compared with clinical follow-up for assessing bone graft viability.
During follow-up, five bone graft segments were surgically removed and confirmed as nonviable-one had a score of 0, although the other four had a score of 1-3 on planar bone scintigraphy. All five bone graft segments were scored 0 on SPECT/CT and eventually confirmed as nonviable. All other graft segments with a score of > 1 on SPECT/CT were viable and uneventful. The anatomical CT information on SPECT/CT images was helpful in discriminating bone graft uptake from adjacent bone or soft tissue uptake.
The absence of tracer uptake by the vascularized bone graft on bone SPECT/CT at 1 week after maxillary or mandibular reconstructive surgery can predict graft failure. Bone SPECT/CT can be used to predict vascularized bone graft viability postoperatively.
我们旨在评估混合骨单光子发射计算机断层扫描(SPECT)/计算机断层扫描(CT)在上颌或下颌血管化骨移植重建手术后预测骨移植存活情况的性能。
我们回顾性分析了45例成年患者在上颌或下颌血管化骨移植重建手术后1周(5 - 8天)拍摄的46张骨平面闪烁显像和SPECT/CT图像。通过视觉分析,两名核医学医生分别在平面骨闪烁显像和SPECT/CT上,将每个骨移植节段的摄取程度与颅骨摄取程度进行评分比较(0 = 无摄取,1 = 摄取较少,2 = 摄取相似,3 = 摄取较多)。将成像结果与临床随访结果进行比较,以评估骨移植的存活情况。
在随访期间,有5个骨移植节段通过手术切除并被证实为无活力——其中1个评分为0,尽管其他4个在平面骨闪烁显像上评分为1 - 3。这5个骨移植节段在SPECT/CT上均评分为0,并最终被证实为无活力。所有其他在SPECT/CT上评分>1的移植节段均存活且情况良好。SPECT/CT图像上的解剖CT信息有助于区分骨移植摄取与相邻骨或软组织摄取。
上颌或下颌重建手术后1周,血管化骨移植在骨SPECT/CT上无示踪剂摄取可预测移植失败。骨SPECT/CT可用于术后预测血管化骨移植的存活情况。